Skip to main content
Clinical Trials/NCT03583203
NCT03583203
Completed
Not Applicable

Efficacy in Patients With Severe Mental Disorders of an Intensive Motivational Interventional Programme Offering Individualized Information on Respiratory Damage for Smoking Cessation

Hospital Universitario Reina Sofia de Cordoba1 site in 1 country230 target enrollmentJuly 12, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Severe Mental Disorder
Sponsor
Hospital Universitario Reina Sofia de Cordoba
Enrollment
230
Locations
1
Primary Endpoint
COPD diagnosis
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Randomized, open label, prospective study with a 12-month follow-up period. The primary objective evaluates the effectiveness of an intensive anti-smoking programme that informs patients of their individual risk of lung damages and the possibilities of prevention. The main measurement will be having given up smoking in month 12, measurement of self-reported abstinence on the 7 previous days and confirmed by a CO-oximeter test< 10 ppm, between the intervention and control group. A total of 9 urban and rural mental health centres will participate in the study. The intervention group will undergo spirometry and presence and the degree of respiratory obstruction will be assessed. Participants will be given individual information to generate a motivational message about the possibilities of prevention and the information will be maintained for three months by sending text messages (SMS) to their mobile phones. The efficacy of the method and the pulmonary damage variables will be evaluated: smoking cessation at the end of follow-up will be confirmed by cooximetry, and the COPD diagnosis and the severity of the staging for disease will be assessed

Registry
clinicaltrials.gov
Start Date
July 12, 2018
End Date
December 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hospital Universitario Reina Sofia de Cordoba
Responsible Party
Principal Investigator
Principal Investigator

Fernando Sarramea Crespo

Principal Investigator

Hospital Universitario Reina Sofia de Cordoba

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 40 and 70
  • Confirmed diagnosis of Bipolar Disorder or Schizophrenia according to Diagnostic and Statistical Manual of Mental Disorder IV (DSM-IV-TR)
  • Active smokers who currently consume at least 10 cigarettes a day, with a cumulative consumption of 10 packets/year or more.

Exclusion Criteria

  • Previous respiratory diagnosis of: asthma, cystic fibrosis, tuberculosis, simple chronic bronchitis, restrictive pulmonary disease or bronchiectasis
  • Acute respiratory symptoms
  • Heart disease or advanced oncological processes
  • Existence of a pathology which makes it advisable not to perform spirometry (recent pneumothorax, recent thoracic or abdominal surgery, aortic aneurysm, unstable angulation, retinal detachment, facial hemiparesis or oral/dental problems)
  • Patients who, due to their intellectual disability or mental pathology, do not understand or cannot be forced to perform spirometry
  • Clinical instability with results of over 14 points on the Hamilton Depression Rating Scale (HDRS), a Young Mania Rating Scale (YMRS) of over 6 or a Positive and Negative Syndrome Scale (PANSS) of over 70

Outcomes

Primary Outcomes

COPD diagnosis

Time Frame: 12 month

Presence of COPD and staging and percentage of forced expiratory volume at one second (FEV1) compared with expected level

Smoking cessation

Time Frame: 12 months

Self-reported abstinence over the previous 7 days, confirmed by cooximetry with expired CO \<10 ppm

Study Sites (1)

Loading locations...

Similar Trials